The 20 Best Status Epilepticus Doctors Near Me in Ann Arbor, MI

Dr. Terman is a neurologist who specializes in caring for patients with seizures and epilepsy. He earned a BS in neuroscience from Brown University in 2009. Then, he completed his MD at the University of Michigan in 2014, and during this time also obtained an MS in Clinical Research which included training in statistics and epidemiology. He then completed his neurology residency at the University of Michigan in 2018, and pursued further subspecialty training during epilepsy fellowship at the University of Michigan. Dr. Terman is rated as a Distinguished provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Status Epilepticus, and Spinal Fusion. Dr. Terman is board certified in Neurology and Epilepsy.

Jack M. Parent, M.D., is a professor of neurology, director of the Neurodevelopment and Regeneration Laboratory, and co-director of the Comprehensive Epilepsy Center in the University of Michigan Medical School.His current research interests include neural stem cell transplantation to treat brain injury and neurodegeneration, and the modification of adult neural stem cells to promote brain repair after stroke or prevent epilepsy.Dr. Parent earned a Bachelor of Arts degree, with distinction, in human biology from Stanford University and his medical degree from the Yale University School of Medicine. He completed a medical internship and neurology residency at the University of California, San Francisco (UCSF), where he was selected chief resident. He stayed at UCSF for clinical fellowship training in epilepsy and clinical neurophysiology, and postdoctoral training in neuroscience research.An internationally recognized research leader in the fields of neural stem cell biology, regeneration after brain injury and epilepsy, Dr. Parent established the Neurodevelopment and Regeneration Laboratory at the U-M in 2000.Dr. Parent is a member of the Epilepsy Foundation of America Research Council, the Medical Advisory Board of the Global Ischemia Foundation, the Independent Science Review Panel of the New Jersey Commission on Brain Injury Research, and the National Scientific Advisory Council of the American Federation for Aging Research. He also serves as an associate editor of Neuroscience Letters, and is on the editorial boards of Experimental Neurology and Epilepsy Currents.He has received several awards for his research, including a Junior Investigator Award from the American Epilepsy Society, a Paul Beeson Physician Faculty Scholars in Aging Award, a Dreifuss-Penry Epilepsy Award from the American Academy of Neurology, and a Grass Foundation Award in Neuroscience from the American Neurological Association. Dr. Parent is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Dravet Syndrome. Dr. Parent is board certified in Neurology and Clinical Neurophysiology.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Mihaylova is board certified in Neurology, Clinical Neurophysiology, and Epilepsy.

Nicholas J. Beimer, MD is a Clinical Instructor in the Department of Neurology in the University of Michigan Medical School. Dr. Beimer has expertise in the treatment of epilepsy, with special clinical and research interest in the care of patients with non-epileptic seizures.After graduating from Kalamazoo College in 2006 with a Bachelor of Arts degree in chemistry, Dr. Beimer received his medical degree from Wayne State University School of Medicine in Detroit, MI and completed a transitional year internship at St. Joseph Mercy Hospital in Ann Arbor, MI. He then completed a neurology residency and clinical neurophysiology fellowship at the University of Michigan, joining the University of Michigan faculty in 2015.Dr. Beimer is an advocate for practicing humanism in medicine and is a member of the Arnold P. Gold Humanism Honor Society and advocates for patients with epilepsy as a Professional Advisor for the Epilepsy Foundation of Michigan.Dr. Beimer enjoys working alongside and teaching trainees of all levels and has been a workshop volunteer at annual meetings of the American Academy of Neurology teaching neuroscience to high school students and serves on the resident selection committee for the neurology residency at the University of Michigan. Dr. Beimer is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Conversion Disorder, and Epilepsy. Dr. Beimer is board certified in Neurology and Epilepsy.

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.His bibliography includes numerous peer-reviewed jornals and publications, abstracts and other media. Dr. Seraji is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Vascular Dementia, and Alzheimer's Disease.

Michael M. Wang, M.D. Ph.D., is an assistant professor of neurology and director of molecular stroke research in the Department of Neurology at the University of Michigan. He also is an assistant professor of molecular and integrative physiology at the U-M and a physician in neurology at the VA Ann Arbor Healthcare System.Dr. Wang's research includes laboratory investigations into the molecular basis of stroke and the interaction between stroke, circadian rhythms and disordered sleep. A major interest of the lab is investigating the causes and treatment of CADASIL (Cerebral Autosomal Dominant Arteriopathy Subcortical Infarcts and Leukoencephalopathy), a devastating inherited cause of stroke and vascular dementia. His other interests include studies of the functions of endogenous hormones (estrogen) and differentiation factors on neurons.He received his bachelor's degree, summa cum laude, from Harvard University and earned his medical degree and doctorate in molecular biology and genetics from Johns Hopkins University (JHU) in 1994. In 1998, he completed his neurology residency at JHU; in 2000, he completed a stroke research fellowship with Drs. Richard Traystman and Patricia Hurn. Dr. Wang spent three years on the neurology faculty at JHU before joining the U-M faculty in 2003. During his time at JHU, he also served as a staff neurologist at the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center, both in Baltimore, Maryland.Dr. Wang was elected to Phi Beta Kappa during his junior year at Harvard and to Alpha Omega Alpha at JHU. While a fellow, he was awarded funding from the National Stroke Association and the American Heart Association, and also received a Burroughs Wellcome Career Award in Biomedical Sciences. His research has been supported by the National Institutes of Health (NIH) since 2001.He has published his scientific work in Nature, Journal of Neuroscience and Stroke, and has served as a member of national grant review committees of the NIH and the American Heart Association. His bibliography includes more than 20 peer-reviewed publications, seven book chapters, and numerous abstracts and clinical papers. He also is an ad hoc reviewer for the Journal of Cerebral Blood Flow and Metabolism, American Journal of Physiology, Stroke, and Neurology, among others.At the U-M, Dr. Wang is involved in medical student pre-clinical education, resident education and clinical studies conducted by the U-M Brain Injury Group. He is a member of the Stroke Council of the American Heart Association and a member of the Society of Neuroscience. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Vascular Dementia, Stroke, Stent Placement, and Transmyocardial Revascularization. Dr. Wang is board certified in Vascular Neurology and Neurology.

Julie Ziobro is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Ziobro is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Myoclonic Epilepsy, and Dravet Syndrome. Dr. Ziobro is board certified in Neurology W/Spec Qual Child Neuro and Epilepsy.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Dr. Sieloff received his bachelor's degree in Biomedical Engineering at the University of Michigan. He then completed both medical school, 2013, and residency, 2017, at University of Michigan, serving as chief neurology resident during his final year of residency. As faculty, he works as a neuro-hospitalist and tele-neurologist, in addition to caring for patients in both the general and multiple sclerosis neurology clinics. Dr. Sieloff is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Generalized Tonic-Clonic Seizure, Seizures, Conversion Disorder, Chronic Polyradiculoneuritis, and Gastrostomy. Dr. Sieloff is board certified in Neurology.

Simon Glynn is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Glynn is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Epilepsy. Dr. Glynn is board certified in Neurology and Epilepsy.

Dr. Venkatakrishna Rajajee completed his medical training at the Madras Medical College in India. He completed his residency in Neurology at the Mount Sinai Medical Center, New York in 2003, followed by fellowships in Stroke/ Vascular Neurology and Neurological Critical Care at the UCLA Medical Center 2003-2005. In addition, he has several years of experience in private practice as an attending physician in medical/ surgical intensive care units. He joined the University of Michigan’s neurosurgery department 2008 as faculty neurointensivist and vascular neurologist. He has served as the medical director of neurocritical care since 2014 and as co-director of the comprehensive stroke center since 2017.Dr. Rajajee has had a clinical, educational, and research interest in critical care ultrasound since 2007. He is a diplomate of the National Board of Echocardiography. He has published several articles on optic nerve ultrasound and transcranial doppler in neurocritical care, and helped pioneer the use of real-time ultrasound guidance during bedside tracheostomy in 2011. Dr. Rajajee developed and directed the Neurocritical Care Society’s (NCS) annual critical care ultrasound workshop between 2012-2014, and has served on the Society of Critical Care Medicine’s (SCCM) Ultrasound Committee. He currently coordinates the University of Michigan’s multidisciplinary critical care ultrasound lecture series.His other interests include the monitoring and management of patients with severe Traumatic Brain Injury (TBI). In 2013, Michigan Medicine signed a memorandum of understanding on collaboration in research and education with the All India Institute of Medical Sciences (AIIMS), New Delhi, with TBI as a major focus. As part of this collaboration, Dr. Rajajee has received funding from the National Institutes of Health (NIH) to study techniques of intracranial pressure assessment applicable to low and middle income nations. He has also received funding from the Department of Defense (DoD) to evaluate noninvasive techniques to assess the brain following TBI.He is a former chair of the Neurocritical Care Society’s Guidelines Committee, and the GRADE methodologist of the NCS guidelines for neuroprognostication in neurocritical care. He is the first author of the 2023 Guidelines for Neuroprognostication in Comatose Adult Survivors of Cardiac Arrest. Dr. Rajajee is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, Gastrostomy, and Transmyocardial Revascularization.

Dr. Elafros graduated Phi Beta Kappa and with honors from Michigan State University in Human Biology and Spanish before completing a Masters of Arts in Bioethics. She then received her MD degree and PhD in Epidemiology from Michigan State University during which time she lived in Zambia for two years to complete her doctoral dissertation which examined the medical and psychosocial burden of HIV and epilepsy among adults in the capital city Lusaka. Dr. Elafros then completed a neurology residency at Johns Hopkins Hospitals, during which time she received an R25 from the National Institutes of Health which allowed her to return to Zambia to examine barriers to care for patients with meningitis. She then joined the University of Michigan for neuromuscular fellowship in 2020.Dr. Elafros provides longitudinal patient care through the outpatient neuromuscular clinic at the University of Michigan. Dr. Elafros is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Myasthenia Gravis, and Seizures. Dr. Elafros is board certified in Neurology and Electrodiagnostic Medicine.

Mikhail Ognenovski is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Ognenovski is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His clinical expertise encompasses Migraine, Migraine with Brainstem Aura, Sporadic Hemiplegic Migraine, and Familial Hemiplegic Migraine.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Craig Williamson is a Neurologist and a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Williamson is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Subarachnoid Hemorrhage, Increased Intracranial Pressure, Thrombectomy, and Stent Placement. Dr. Williamson is board certified in Neurology and Neurocritical Care.

Jamal Chirri is a Neurologist practicing medicine in Ypsilanti, Michigan. Dr. Chirri is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Stroke, Seizures, Transient Ischemic Attack (TIA), Stent Placement, and Transmyocardial Revascularization. Dr. Chirri is board certified in American Osteopathic Board Of Neurology & Psychiatry.

Jonathan Gaillard is a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Gaillard is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His clinical expertise encompasses Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, and Epilepsy. Dr. Gaillard is board certified in Neurology W/Spec Qual Child Neuro.

Deepa Malaiyandi is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Malaiyandi is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her clinical expertise encompasses Status Epilepticus, Stroke, Seizures, and Cramp-Fasciculation Syndrome. Dr. Malaiyandi is board certified in Neurology and Neurocritical Care.

Jonathan Zande is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Zande is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Epilepsy, and Memory Loss. Dr. Zande is board certified in Neurology and Epilepsy.

Yu Wang is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Generalized Tonic-Clonic Seizure, Seizures, Memory Loss, and Landau-Kleffner Syndrome.